Ken Griffin’s GlucoTrack GCTK Stock Holding History

Ken Griffin’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4	Closed	-$7.27K	–	14677
2024 Q1	$7.27K	Sell	4 -3	-43%	-$4.71K	﹤0.01%	13623
2023 Q4	$10.2K	Buy	7 +2	+40%	+$2.65K	﹤0.01%	13113
2023 Q3	$8.34K	Buy	+5	New	+$8.98K	﹤0.01%	13195

Other funds holding GCTK

Alerus Financial Grand Forks, North Dakota $2.29B AUM 30.87% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ken Griffin's GCTK Position: Q2 2024 in Review

Ken Griffin sold out of GlucoTrack (GCTK) in Q2 2024, closing a stake of 4 shares — an estimated $7.27K sold.

Ken Griffin first reported a position in GCTK in Q3 2023 and held it in 3 quarters. The position peaked at $10.2K in Q4 2023. 3 funds tracked by Wall St. Rank hold GCTK as of Q2 2024.

Ken Griffin reported no remaining GlucoTrack position as of Q2 2024 after selling out during the quarter.
Ken Griffin sold 4 GlucoTrack shares in Q2 2024, an estimated $7.27K.
Ken Griffin first reported a position in GlucoTrack in Q3 2023 and held it in 3 quarters.
Ken Griffin's GlucoTrack position peaked at $10.2K in Q4 2023.
3 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.